Skip to contentRatcliffe Liam — ARVINAS, INC. insider: 135 transactions · InsiderLensRatcliffe Liam
- 10% owner at MARSHALL EDWARDS INC · on record since Nov 25, 2013
- 10% owner at Oxford Immunotec Global PLC · on record since Nov 21, 2013
- Former 10% beneficial owner at Relypsa Inc · on record since Nov 20, 2013
- Director at OnKure Therapeutics, Inc. · on record since Apr 1, 2026
- Director at ARRAY BIOPHARMA INC · on record since Apr 30, 2012
- 10% owner at Relypsa Inc · on record since Nov 14, 2013
- 10% owner at iRhythm Holdings, Inc. · on record since Oct 25, 2016
- Former 10% Beneficial Owner at Oxford Immunotec Global PLC · on record since Dec 3, 2013
- 10% owner at Versartis, Inc. · on record since Mar 28, 2014
- 10% owner at CONCERT PHARMACEUTICALS, INC. · on record since Feb 21, 2014
- 10% owner at Comtrix, Inc. · on record since Mar 20, 2014
- Director at Upstream Bio, Inc. · on record since Jun 11, 2026
- 10% owner at Durata Therapeutics, Inc. · on record since Nov 18, 2014
- Director at Edge Therapeutics, Inc. · on record since Jun 23, 2016
- Director at Deciphera Pharmaceuticals, Inc. · on record since Sep 28, 2017
- 10% owner at Deciphera Pharmaceuticals, Inc. · on record since Sep 28, 2017
- Director at Cogent, Inc. · on record since Mar 28, 2018
- 10% owner at Iterum Therapeutics plc · on record since May 31, 2018
- Director at Aptinyx Inc. · on record since Jun 26, 2018
- 10% owner at Aptinyx Inc. · on record since Jun 26, 2018
- Director at ARVINAS, INC. · on record since Sep 26, 2018
- 10% owner at ARVINAS, INC. · on record since Sep 26, 2018
- Director at Passage BIO, Inc. · on record since Feb 27, 2020
- Director at Climb Bio, Inc. · on record since Aug 11, 2021
- Director at Disc Medicine, Inc. · on record since Jan 3, 2023
Insider trading activity of Ratcliffe Liam
- Transactions on record
- 135
- since Oct 26, 2012
- Open-market buys
- 13
- $68.4M
- Open-market sells
- 47
- $71.6M
- Companies traded
- 13
- last filing Jun 23, 2026
Figures computed from official regulatory filings — methodology.
Companies where Ratcliffe Liam has traded
- Disc Medicine, Inc.5 tx · Jun 23, 2026
- Upstream Bio, Inc.3 tx · Jun 11, 2026
- OnKure Therapeutics, Inc.2 tx · Jun 8, 2026
- Climb Bio, Inc.4 tx · Jun 28, 2024
- ARVINAS, INC.57 tx · $93M · Jun 21, 2022
- Passage BIO, Inc.7 tx · $10M · May 28, 2021
- Cogent, Inc.11 tx · $6.7M · Jun 18, 2019
- Aptinyx Inc.11 tx · $4M · Apr 2, 2019
- Edge Therapeutics, Inc.6 tx · $152.3K · Mar 18, 2019
- Deciphera Pharmaceuticals, Inc.
Track record of Ratcliffe Liam
Statistical track record
Free- Open-market buys
- 13
- Last buy
- Dec 18, 2020
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Ratcliffe Liam
Co-insiders of Ratcliffe Liam
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
12 tx · $6.4M · May 21, 2018
New Leaf Ventures II, L.P.Comtrix, Inc. +5
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 23, 2026 | AwardD | 6,212 | 0.00 USD | — | SEC |
| Jun 11, 2026 | AwardD | 17,096 | 0.00 USD | $0 | SEC |
| Jun 8, 2026 | AwardD | 1,275 | 0.00 USD | $0 | SEC |
| Apr 1, 2026 | AwardD | 15,300 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2025 | AwardD | 17,096 | 0.00 USD | $0 | SEC |
| Oct 15, 2024 | AwardD | 17,096 | 0.00 USD | $0 | SEC |
| Jun 28, 2024 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jun 9, 2023 | AwardD | 7,136 | 0.00 USD | $0 | SEC |
| May 22, 2023 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Jan 3, 2023 | AwardD | 7,000 | 0.00 USD | $0 | SEC |
| Jun 21, 2022 | AwardD | 10,192 | 0.00 USD | $0 | SEC |
| Jun 1, 2022 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Dec 16, 2021 | Sell | -5,695 | 65.74 USD | $374.4K | SEC |
| Dec 16, 2021 | Sell | -700 | 64.20 USD | $44.9K | SEC |
| Dec 16, 2021 | Sell | -119,456 | 66.01 USD | $7.9M | SEC |
| Dec 16, 2021 | Sell | -40,292 | 67.46 USD | $2.7M | SEC |
| Dec 16, 2021 | Sell | -37,206 | 68.97 USD | $2.6M | SEC |
| Dec 16, 2021 | Sell | -67,549 | 66.50 USD | $4.5M | SEC |
| Dec 16, 2021 | Sell | -36,308 | 65.38 USD | $2.4M | SEC |
| Dec 16, 2021 | Sell | -48,499 | 69.66 USD | $3.4M | SEC |
| Nov 15, 2021 | Sell | -1,498 | 89.16 USD | $133.6K | SEC |
| Nov 15, 2021 | Sell | -1,852 | 90.18 USD | $167K | SEC |
| Nov 15, 2021 | Sell | -17,752 | 85.07 USD | $1.5M | SEC |